These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25659871)

  • 1. Alterations of intestinal lipoprotein metabolism in diabetes mellitus and metabolic syndrome.
    Arca M
    Atheroscler Suppl; 2015 Feb; 17():12-6. PubMed ID: 25659871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial lipid and apolipoprotein responses following three consecutive meals associate with liver fat content in type 2 diabetes and the metabolic syndrome.
    Tushuizen ME; Pouwels PJ; Bontemps S; Rustemeijer C; Matikainen N; Heine RJ; Taskinen MR; Diamant M
    Atherosclerosis; 2010 Jul; 211(1):308-14. PubMed ID: 20227695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of medications used for the management of diabetes and obesity on postprandial lipid metabolism.
    Eleftheriadou I; Grigoropoulou P; Katsilambros N; Tentolouris N
    Curr Diabetes Rev; 2008 Nov; 4(4):340-56. PubMed ID: 18991602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disturbances of lipoprotein metabolism in metabolic syndrome].
    Czyzewska M; Wolska A; Cwiklińska A; Kortas-Stempak B; Wróblewska M
    Postepy Hig Med Dosw (Online); 2010 Jan; 64():1-10. PubMed ID: 20093718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal lipid absorption and transport in type 2 diabetes.
    Vergès B
    Diabetologia; 2022 Oct; 65(10):1587-1600. PubMed ID: 35908083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nobiletin Prevents High-Fat Diet-Induced Dysregulation of Intestinal Lipid Metabolism and Attenuates Postprandial Lipemia.
    Morrow NM; Trzaskalski NA; Hanson AA; Fadzeyeva E; Telford DE; Chhoker SS; Sutherland BG; Edwards JY; Huff MW; Mulvihill EE
    Arterioscler Thromb Vasc Biol; 2022 Feb; 42(2):127-144. PubMed ID: 34911361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of intestinal lipoprotein overproduction in insulin resistant humans.
    Duez H; Pavlic M; Lewis GF
    Atheroscler Suppl; 2008 Sep; 9(2):33-8. PubMed ID: 18676184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women.
    Mekki N; Christofilis MA; Charbonnier M; Atlan-Gepner C; Defoort C; Juhel C; Borel P; Portugal H; Pauli AM; Vialettes B; Lairon D
    J Clin Endocrinol Metab; 1999 Jan; 84(1):184-91. PubMed ID: 9920081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat-loading test.
    Lewis GF; O'Meara NM; Soltys PA; Blackman JD; Iverius PH; Druetzler AF; Getz GS; Polonsky KS
    J Clin Endocrinol Metab; 1990 Oct; 71(4):1041-50. PubMed ID: 2401706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
    Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH
    Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin treatment upregulates intestinal lipid secretion pathways in a rodent model of the metabolic syndrome.
    Borthwick F; Mangat R; Warnakula S; Jacome-Sosa M; Vine DF; Proctor SD
    Atherosclerosis; 2014 Jan; 232(1):141-8. PubMed ID: 24401228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial lipemia associates with liver fat content.
    Matikainen N; Mänttäri S; Westerbacka J; Vehkavaara S; Lundbom N; Yki-Järvinen H; Taskinen MR
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3052-9. PubMed ID: 17488790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of postprandial hyperlipidaemia--remnants and coronary artery disease.
    Karpe F
    Diabet Med; 1997 Aug; 14 Suppl 3():S60-6. PubMed ID: 9272616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes.
    Bozzetto L; Annuzzi G; Corte GD; Patti L; Cipriano P; Mangione A; Riccardi G; Rivellese AA
    Atherosclerosis; 2011 Jul; 217(1):142-8. PubMed ID: 21481394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production: evidence for predominance of GLP-2-stimulated postprandial lipemia in normal and insulin-resistant states.
    Hein GJ; Baker C; Hsieh J; Farr S; Adeli K
    Diabetes; 2013 Feb; 62(2):373-81. PubMed ID: 23028139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postprandial hyperlipidemia, small and dense LDL, HDL sub-fractions].
    Braschi S
    Ann Med Interne (Paris); 2001 Apr; 152(3):162-8. PubMed ID: 11431575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.